Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RWGJQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Control-AL1- LP39
|
|||||
| Synonyms |
Control-AL1- LP39
Click to Show/Hide
|
|||||
| Organization |
Regeneron Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.6
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines
|
|||||
| Combination Type |
LP39
|
|||||